📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-021-01442-6

PubMed Identifier: 34172930

Publication URI: http://europepmc.org/abstract/MED/34172930

Type: Journal Article/Review

Volume: 125

Parent Publication: British journal of cancer

Issue: 5

ISSN: 0007-0920